Of note, this tendency was also apparent for murine glioma cells with a lower proliferative potential and different genetic background—namely, PNMG106 cells with homozygous deletion of Tp53 and Nf1 (Fig. S4 and Video S1). The gene discussed is NF1; the disease is central nervous system cancer.